3b25: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
[[Image:3b25.jpg|left|200px]] | |||
The | <!-- | ||
The line below this paragraph, containing "STRUCTURE_3b25", creates the "Structure Box" on the page. | |||
You may change the PDB parameter (which sets the PDB file loaded into the applet) | |||
or the SCENE parameter (which sets the initial scene displayed when the page is loaded), | |||
or leave the SCENE parameter empty for the default display. | |||
--> | |||
{{STRUCTURE_3b25| PDB=3b25 | SCENE= }} | |||
===Hsp90 alpha N-terminal domain in complex with an inhibitor CH4675194=== | |||
<!-- | |||
The line below this paragraph, {{ABSTRACT_PUBMED_21875802}}, adds the Publication Abstract to the page | |||
(as it appears on PubMed at http://www.pubmed.gov), where 21875802 is the PubMed ID number. | |||
--> | |||
{{ABSTRACT_PUBMED_21875802}} | |||
==About this Structure== | |||
[[3b25]] is a 1 chain structure with sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3B25 OCA]. | |||
==Reference== | |||
<ref group="xtra">PMID:021875802</ref><references group="xtra"/> | |||
[[Category: Homo sapiens]] | |||
[[Category: Fukami, T A.]] | |||
[[Category: Ono, N.]] | |||
[[Category: Chaperone-chaperone inhibitor complex]] |
Revision as of 09:28, 14 September 2011
Hsp90 alpha N-terminal domain in complex with an inhibitor CH4675194Hsp90 alpha N-terminal domain in complex with an inhibitor CH4675194
Template:ABSTRACT PUBMED 21875802
About this StructureAbout this Structure
3b25 is a 1 chain structure with sequence from Homo sapiens. Full crystallographic information is available from OCA.
ReferenceReference
- ↑ Miura T, Fukami TA, Hasegawa K, Ono N, Suda A, Shindo H, Yoon DO, Kim SJ, Na YJ, Aoki Y, Shimma N, Tsukuda T, Shiratori Y. Lead generation of heat shock protein 90 inhibitors by a combination of fragment-based approach, virtual screening, and structure-based drug design. Bioorg Med Chem Lett. 2011 Oct 1;21(19):5778-83. Epub 2011 Aug 6. PMID:21875802 doi:10.1016/j.bmcl.2011.08.001